Literature DB >> 18282013

Transparency of economic evaluations of health technologies.

Joan Rovira.   

Abstract

Mesh：

Year:  2008        PMID： 18282013     DOI： 10.2165/00019053-200826030-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  13 in total

Review 1.  Conflict of interest in industry-sponsored economic evaluations: real or imagined?

Authors:  M Barbieri; M F Drummond
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

2.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  N Engl J Med       Date:  2004-09-08       Impact factor: 91.245

3.  Economic evaluation of pharmaceuticals: science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

Review 4.  A comparative review of pharmacoeconomic guidelines.

Authors:  P Jacobs; J Bachynsky; J F Baladi
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

5.  Scientists behaving badly.

Authors:  Brian C Martinson; Melissa S Anderson; Raymond de Vries
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

Authors:  A L Hillman; J M Eisenberg; M V Pauly; B S Bloom; H Glick; B Kinosian; J S Schwartz
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

7.  The journal's policy on cost-effectiveness analyses.

Authors:  J P Kassirer; M Angell
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

8.  Making economic evaluations respectable.

Authors:  U E Reinhardt
Journal:  Soc Sci Med       Date:  1997-08       Impact factor: 4.634

9.  Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology.

Authors: 
Journal:  Ann Intern Med       Date:  1995-07-01       Impact factor: 25.391

10.  Medical journals are an extension of the marketing arm of pharmaceutical companies.

Authors:  Richard Smith
Journal:  PLoS Med       Date:  2005-05-17       Impact factor: 11.069
View more
  3 in total

1.  Meandering down the road to transparency.

Authors:  Christopher I Carswell; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis.

Authors:  Ferrán Catalá-López; Adolfo Alonso-Arroyo; Rafael Aleixandre-Benavent; Manuel Ridao; Máxima Bolaños; Anna García-Altés; Gabriel Sanfélix-Gimeno; Salvador Peiró
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

Review 3.  When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.

Authors:  Ferrán Catalá-López; Gabriel Sanfélix-Gimeno; Manuel Ridao; Salvador Peiró
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.